PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 58 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,000 | +200.0% | 9,830 | +521.4% | 0.00% | – |
| Q1 2022 | $2,000 | -83.3% | 1,582 | -65.6% | 0.00% | – |
| Q4 2021 | $12,000 | +300.0% | 4,600 | +360.0% | 0.00% | – |
| Q3 2021 | $3,000 | -80.0% | 1,000 | -75.5% | 0.00% | – |
| Q2 2021 | $15,000 | -46.4% | 4,087 | -49.9% | 0.00% | – |
| Q1 2021 | $28,000 | +600.0% | 8,150 | +523.1% | 0.00% | – |
| Q4 2020 | $4,000 | -89.2% | 1,308 | -83.9% | 0.00% | – |
| Q2 2020 | $37,000 | +12.1% | 8,121 | -17.7% | 0.00% | – |
| Q1 2020 | $33,000 | -70.0% | 9,863 | -45.4% | 0.00% | – |
| Q4 2019 | $110,000 | +103.7% | 18,059 | +39.8% | 0.00% | – |
| Q3 2019 | $54,000 | +20.0% | 12,920 | +278.4% | 0.00% | – |
| Q2 2019 | $45,000 | +164.7% | 3,414 | +95.6% | 0.00% | – |
| Q1 2019 | $17,000 | – | 1,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5,400,000 | 0.70% |
| NEA Management Company, LLC | 6,643,704 | $22,323,000 | 0.59% |
| DAFNA Capital Management LLC | 320,542 | $1,077,000 | 0.32% |
| Platform Technology Partners | 141,025 | $474,000 | 0.23% |
| Parkman Healthcare Partners LLC | 110,547 | $371,000 | 0.10% |
| Rock Springs Capital Management LP | 1,314,374 | $4,416,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 140,341 | $472,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 65,000 | $218,000 | 0.04% |
| Virtu Financial LLC | 28,821 | $97,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 127,600 | $429,000 | 0.01% |